Joel Greenblatt's position in Abbott Laboratories is currently worth $12.5 Million. That's 0.44% of their equity portfolio (23rd largest holding). The first Abbott Laboratories trade was made in Q4 2010. Since then Joel Greenblatt bought shares nineteen more times and sold shares on nineteen occasions. The stake costed the investor $5.33 Million, netting the investor a gain of 134% so far.